Motorcar Parts of America heads into its fiscal second-quarter report with an unusual mix of ambition and strain. Last quarter management unveiled the Centric brake-brands acquisition and talked up brakes as a second mega-category, yet the same report showed gross margin sliding, cash going out the door and leverage climbing. The September quarter is the first real chance to see whether the reaffirmed full-year outlook rests on actual order flow or on hope that the timing problems of recent quarters finally fade.
Wall Street is looking for earnings of $0.18 per share on revenue of about $194.8 million. That EPS figure would be well above the $0.07 earned a year ago, roughly a 157% jump, but the top line is expected to shrink about 12% from $221.5 million. The more useful comparison is sequential: revenue would need to climb roughly 16% from the $168 million posted in the June quarter, and earnings would need to swing sharply from last quarter's loss of $0.71. In other words, the Street is betting on a margin and profitability recovery rather than a volume story.
That bet matters because of what the full-year guidance demands. Management still expects fiscal 2027 revenue of $780 million to $800 million, and the consensus sits at $800 million, the very top of the range. If the second quarter lands near $195 million, the first half would total roughly $363 million, leaving about $427 million to $437 million for the final two quarters. That implies quarterly sales north of $210 million in the back half, a level the company has not been producing lately. A quarter at or above consensus, paired with evidence that new-business shipments are starting to flow, would support the plan. A shortfall, or more talk about customers still working through a liquidated competitor's inventory, would make the top end of guidance look stretched and put pressure on the Street's number.
Gross margin is the second test. The June quarter's 16.2% reported margin, 20.2% adjusted, compared poorly with the 25.8% adjusted figure in the prior quarter, with management blaming a peso-driven currency hit of about $3.5 million, non-cash items, one-time costs and lighter volume. Higher sales should absorb fixed costs better, so a meaningful sequential rebound toward the low-to-mid 20s on an adjusted basis would validate the claim that the dip was transitory. If currency headwinds persist and margins only creep higher, the earnings recovery embedded in consensus becomes harder to reach. Cash flow and the balance sheet deserve equal attention. Net bank debt rose to $99.7 million, or 1.26 times leverage, as inventory was built for new programs. Some build is reasonable ahead of a ramp, but another quarter of rising debt without matching sales growth would raise questions, especially with Centric integration costs ahead.
The market has grown noticeably more skeptical. Sentiment has swung from essentially neutral before the last report to firmly bearish now. The stock is down only slightly since that report and has actually held up better than the S&P 500, but it trades at $10.31, below its 200-day moving average near $11.82 and close to the bottom of its post-earnings range of $9.80 to $12.83. That entire range sits beneath the prior quarter's trough of $12.94, a sign the shares were repriced lower and have not recovered.
The central question is simple: is the back-half ramp showing up? Updates on the timing of the more than $100 million in annualized business not yet in guidance, progress on the Centric relaunch, and confirmation of a path to a run-rate above $900 million by fiscal year-end will shape the reaction as much as the headline numbers. Solid sequential growth with recovering margins and stabilizing debt keeps the narrative intact. Anything less leaves a bold strategy resting on a weakening near-term foundation.